Published in Microb Drug Resist on June 07, 2010
"Stormy waters ahead": global emergence of carbapenemases. Front Microbiol (2013) 2.74
The Acinetobacter baumannii Oxymoron: Commensal Hospital Dweller Turned Pan-Drug-Resistant Menace. Front Microbiol (2012) 2.45
Optimized method for Acinetobacter species carbapenemase detection and identification by matrix-assisted laser desorption ionization-time of flight mass spectrometry. J Clin Microbiol (2013) 1.00
Genetic diversity of OXA-51-like genes among multidrug-resistant Acinetobacter baumannii in Riyadh, Saudi Arabia. Eur J Clin Microbiol Infect Dis (2014) 0.95
Antimicrobial active herbal compounds against Acinetobacter baumannii and other pathogens. Front Microbiol (2015) 0.89
In-silico modeling of a novel OXA-51 from β-lactam-resistant Acinetobacter baumannii and its interaction with various antibiotics. J Mol Model (2012) 0.77
High prevalence of the PER-1 gene among carbapenem-resistant Acinetobacter baumannii in Riyadh, Saudi Arabia. Eur J Clin Microbiol Infect Dis (2016) 0.75
Population structure of Pseudomonas aeruginosa. Proc Natl Acad Sci U S A (2007) 2.56
Clinical outbreak of linezolid-resistant Staphylococcus aureus in an intensive care unit. JAMA (2010) 2.52
Resistance to linezolid is mediated by the cfr gene in the first report of an outbreak of linezolid-resistant Staphylococcus aureus. Clin Infect Dis (2010) 2.02
In vitro activities of tigecycline (GAR-936) against recently isolated clinical bacteria in Spain. Antimicrob Agents Chemother (2002) 1.65
In vitro activity of tedizolid (TR-700) against linezolid-resistant staphylococci. J Antimicrob Chemother (2011) 1.24
Elevated linezolid resistance in clinical cfr-positive Staphylococcus aureus isolates is associated with co-occurring mutations in ribosomal protein L3. Antimicrob Agents Chemother (2010) 1.20
Identification of Acinetobacter species: is Bruker biotyper MALDI-TOF mass spectrometry a good alternative to molecular techniques? Infect Genet Evol (2012) 1.19
Overexpression of the multidrug efflux pump SmeDEF impairs Stenotrophomonas maltophilia physiology. J Antimicrob Chemother (2004) 1.14
Structure-activity relationships of diverse oxazolidinones for linezolid-resistant Staphylococcus aureus strains possessing the cfr methyltransferase gene or ribosomal mutations. Antimicrob Agents Chemother (2010) 1.12
Comparative activity of carbapenem testing: the COMPACT study. J Antimicrob Chemother (2011) 1.11
Macrolide and tetracycline resistance and molecular relationships of clinical strains of Streptococcus agalactiae. Antimicrob Agents Chemother (2002) 1.10
[Significant increase in the colonisation of Staphylococcus aureus among medical students during their hospital practices]. Enferm Infecc Microbiol Clin (2012) 1.01
Optimized method for Acinetobacter species carbapenemase detection and identification by matrix-assisted laser desorption ionization-time of flight mass spectrometry. J Clin Microbiol (2013) 1.00
The coordinate regulation of multiple terminal oxidases by the Pseudomonas putida ANR global regulator. Environ Microbiol (2008) 0.99
Tissue destruction in periodontitis: bacteria or cytokines fault? Quintessence Int (2005) 0.95
Distribution of tetracycline resistance genes tet(M), tet(O), tet(L) and tet(K) in blood isolates of viridans group streptococci harbouring erm(B) and mef(A) genes. Susceptibility to quinupristin/dalfopristin and linezolid. Int J Antimicrob Agents (2003) 0.95
Changing patterns of fluoroquinolone resistance among Bacteroides fragilis group organisms over a 6-year period (1997-2002). Diagn Microbiol Infect Dis (2005) 0.95
High prevalence of viable Mycobacterium avium subspecies paratuberculosis in Crohn's disease. World J Gastroenterol (2010) 0.93
Comparative in vitro activity and the inoculum effect of ertapenem against Enterobacteriaceae resistant to extended-spectrum cephalosporins. Int J Antimicrob Agents (2006) 0.89
[Antimicrobial treatment of exacerbation in chronic obstructive pulmonary disease: 2007 consensus statement]. Arch Bronconeumol (2008) 0.89
Comparative activities of TR-700 (torezolid) against staphylococcal blood isolates collected in Spain. Antimicrob Agents Chemother (2010) 0.87
Comparative in vitro activities of tigecycline (GAR-936) and other antimicrobial agents against Stenotrophomonas maltophilia. J Antimicrob Chemother (2002) 0.87
Resistance trends of the Bacteroides fragilis group over a 10-year period, 1997 to 2006, in Madrid, Spain. Antimicrob Agents Chemother (2008) 0.87
In vitro activity of tigecycline (GAR-936) and other antimicrobials against tetracycline- and ciprofloxacin-resistant Campylobacter clinical isolates. Int J Antimicrob Agents (2006) 0.87
In vitro activity of telithromycin against viridans group streptococci and Streptococcus bovis isolated from blood: antimicrobial susceptibility patterns in different groups of species. Antimicrob Agents Chemother (2005) 0.86
Methylation profiling in non-small cell lung cancer: clinical implications. Int J Oncol (2011) 0.86
Differences in the DNA sequence of the translational attenuator of several constitutively expressed erm(A) genes from clinical isolates of Streptococcus agalactiae. J Antimicrob Chemother (2005) 0.85
Phylogeny of G9 rotavirus genotype: a possible explanation of its origin and evolution. J Clin Virol (2008) 0.85
Clinical guidelines for the management of cancer patients with neutropenia and unexplained fever. Int J Antimicrob Agents (2005) 0.83
[Increasing prevalence of fosfomycin resistance in extended-spectrum-beta-lactamase-producing Escherichia coli urinary isolates (2005-2009-2011)]. Rev Esp Quimioter (2013) 0.82
Poly (ADP-ribose) polymerase 3 (PARP3), a potential repressor of telomerase activity. J Exp Clin Cancer Res (2014) 0.82
Diversity of the G3 genes of human rotaviruses in isolates from Spain from 2004 to 2006: cross-species transmission and inter-genotype recombination generates alleles. J Gen Virol (2009) 0.81
Staphylococcus aureus bacteremic pneumonia: differences between community and nosocomial acquisition. Int J Infect Dis (2003) 0.81
Prevalence of macrolide and tetracycline resistance mechanisms in Streptococcus pyogenes isolates and in vitro susceptibility to telithromycin. J Antimicrob Chemother (2002) 0.81
Rapid identification of clinical isolates of Bacteroides species by matrix-assisted laser-desorption/ionization time-of-flight mass spectrometry. Anaerobe (2011) 0.81
Antimicrobial activity of tigecycline against clinical isolates from Spanish medical centers. Second multicenter study. Diagn Microbiol Infect Dis (2006) 0.81
Differential expression of senescence and cell death factors in non-small cell lung and colorectal tumors showing telomere attrition. Oncology (2012) 0.80
Comparative in vitro activity of ceftobiprole against Gram-positive cocci. Int J Antimicrob Agents (2010) 0.80
Significance of nested PCR and quantitative real time PCR for cytomegalovirus detection in renal transplant recipients. Int J Antimicrob Agents (2004) 0.78
Trends in nalidixic acid resistance in nontyphoidal Salmonella isolated from 1999 to 2002: decreased susceptibility to 6 fluoroquinolones. Diagn Microbiol Infect Dis (2005) 0.78
Antimicrobial susceptibility and macrolide resistance genes in Enterococcus faecium with reduced susceptibility to quinupristin-dalfopristin: level of quinupristin-dalfopristin resistance is not dependent on erm(B) attenuator region sequence. Diagn Microbiol Infect Dis (2008) 0.77
Detection and genotyping of human respiratory viruses in clinical specimens from children with acute respiratory tract infections. Rev Esp Quimioter (2013) 0.77
Present situation in the treatment of invasive fungal infection. Int J Antimicrob Agents (2008) 0.77
Prognostic value of telomere function in gastric cancers with and without microsatellite instability. Eur J Gastroenterol Hepatol (2015) 0.77
Recommendations for vaccination against pneumococcus in kidney patients in Spain. Nefrologia (2014) 0.76
Synthesis, antiviral and cytostatic activities, of carbocyclic nucleosides incorporating a modified cyclopentane ring. IV. Adenosine and uridine analogues. Nucleosides Nucleotides Nucleic Acids (2002) 0.76
Fluoroquinolone resistance among invasive viridans group streptococci and Streptococcus bovis isolated in Spain. Int J Antimicrob Agents (2007) 0.76
Elastic image registration of 2-D gels for differential and repeatability studies. Proteomics (2008) 0.75
Generation of HLA-B*1516/B*1567/B*1595 and B*1517 alleles (B15 specific group) by transpecies evolution. Hum Immunol (2007) 0.75
[Cellulitis after a cat bite]. Rev Esp Quimioter (2009) 0.75
[Comparative study of the in vitro activity of tigecycline against multiresistant Enterococcus faecium isolates]. Enferm Infecc Microbiol Clin (2009) 0.75
[The role of anaerobes in infectious diseases]. Enferm Infecc Microbiol Clin (2010) 0.75
Melioidosis presenting as sepsis syndrome: a case report. Int J Infect Dis (2010) 0.75
[Antimicrobial sensitivity of hippurate-negative Campylobacter and Helicobacter pullorum strains isolated from patients with diarrhea]. Rev Esp Quimioter (2011) 0.75
[Clinical use of rapid assays for the detection of influenza An/H1N1]. Rev Esp Quimioter (2010) 0.75
[The journal]. Enferm Infecc Microbiol Clin (2002) 0.75
[Epidemiologic study of infection by resistant gram-positive bacteria (G + R Study)]. Enferm Infecc Microbiol Clin (2003) 0.75